SEC Form D filing
Nuclein, LLC
Biotech · Series A · Regulation D 506(b) · TX · Filed June 22, 2026
- Offering amount
- $11.1M
- Exemption
- Reg D 506(b)
- Issuer state
- TX
- Filing date
- June 22, 2026
- Signature date
- June 22, 2026
- CIK
- 0001787352
Summary
Auto-generatedNuclein, LLC's name suggests a biotechnology focus, placing it in the biotech vertical. The $11.1M offering amount aligns with a series-a stage.
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.